The U.S. Food and Drug Administration has approved Banamine Transdermal (flunixin transdermal solution) for the control of pain associated with foot rot and the control of
pyrexia associated with bovine respiratory disease.Banamine Transdermal, produced by Merck Animal Health, is the first new animal drug approved in the United States for controlling pain in cattle.
Not exact matches
Common adverse events (AEs)
associated with inotuzumab ozogamicin include abdominal pain, anemia, fatigue, febrile neutropenia, headache, hemorrhage, hyperbilirubinemia, infection, leukopenia, liver damage, nausea, neutropenia,
pyrexia, and thrombocytopenia.
Signs
associated with acute pancreatitis are variable and non-specific Common findings in dogs: anorexia, vomiting, abdominal pain, depression, diarrhoea and
pyrexia Common findings in cats: lethargy, anorexia, dehydration; vomiting and abdominal pain less likely